{"id":"immediate-release-morphine-sulphate","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Constipation"},{"rate":"20-30","effect":"Nausea"},{"rate":"20-30","effect":"Drowsiness"},{"rate":"10-20","effect":"Dizziness"},{"rate":null,"effect":"Respiratory depression"},{"rate":null,"effect":"Dependence/tolerance"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Morphine is a mu-opioid receptor agonist that modulates pain perception by binding to opioid receptors in the brain, spinal cord, and peripheral tissues. This binding inhibits the transmission of pain signals and produces analgesic, euphoric, and sedative effects. Immediate-release formulations are designed for rapid onset of action, typically used for acute pain management.","oneSentence":"Morphine sulphate binds to opioid receptors in the central and peripheral nervous system to produce analgesia and sedation.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:15:40.157Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Acute pain management"},{"name":"Moderate to severe pain"}]},"trialDetails":[{"nctId":"NCT02824276","phase":"PHASE1","title":"Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2017-01-06","conditions":"Low Back Pain","enrollment":35},{"nctId":"NCT06423703","phase":"PHASE3","title":"A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy","status":"COMPLETED","sponsor":"Tris Pharma, Inc.","startDate":"2024-07-18","conditions":"Acute Pain","enrollment":240},{"nctId":"NCT05006079","phase":"PHASE2","title":"Opioid/Benzodiazepine Polydrug Abuse: Aim 3","status":"RECRUITING","sponsor":"Wayne State University","startDate":"2024-03-13","conditions":"Opioid Abuse, Benzodiazepine Abuse, Polysubstance Abuse","enrollment":24},{"nctId":"NCT04110665","phase":"PHASE4","title":"Multimodal Analgesia Strategies After Major Shoulder Ambulatory Surgery","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2017-09-01","conditions":"Tendon Injuries","enrollment":92},{"nctId":"NCT03726268","phase":"PHASE4","title":"Optimizing Outpatient Anesthesia (OSPREy-Outpatient Surgery Pain Relief Enhancement)","status":"COMPLETED","sponsor":"Duke University","startDate":"2018-11-29","conditions":"Opioid Use, Pain, Postoperative","enrollment":907},{"nctId":"NCT04785768","phase":"PHASE3","title":"IV PCA With or Without Continuous Dose vs Oral Opioid to Maintain Analgesia for Severe Cancer Pain After Successful Titration","status":"COMPLETED","sponsor":"Fujian Cancer Hospital","startDate":"2021-07-01","conditions":"Cancer Pain","enrollment":1372},{"nctId":"NCT06897917","phase":"PHASE4","title":"Real World Study of Oxycodone/Naloxone Sustained-Release Tablets (Mimeixin) for Patients With Severe Cancer Pain","status":"NOT_YET_RECRUITING","sponsor":"Henan Cancer Hospital","startDate":"2025-04","conditions":"Opioid-Induced Constipation, Pain Cancer","enrollment":203},{"nctId":"NCT06864312","phase":"PHASE4","title":"Rebound Pain Following Regional Anaesthesia for Ankle Fracture Surgery","status":"COMPLETED","sponsor":"University College Cork","startDate":"2023-10-16","conditions":"Ankle Fracture (bimalleolar Equivalent, Bimalleolar, or Trimalleolar), Ankle Fracture - Lateral Malleolus, Ankle Fracture - Medial Malleolus","enrollment":120},{"nctId":"NCT05846451","phase":"EARLY_PHASE1","title":"Evaluating a Potential Pharmacokinetic Kratom-oxycodone Interaction Concurrent With Clinical Endpoints","status":"RECRUITING","sponsor":"Washington State University","startDate":"2023-06-01","conditions":"Herbal Interaction","enrollment":16},{"nctId":"NCT06212622","phase":"","title":"Is the Rate of Early Mobilisation in Hip Fracture Patients Using Alfentanil Better Than Standard Opioid Analgesia?","status":"COMPLETED","sponsor":"NHS Lothian","startDate":"2024-03-04","conditions":"Hip Injuries, Hip Fractures, Pain","enrollment":64},{"nctId":"NCT05567354","phase":"PHASE1","title":"A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)","status":"COMPLETED","sponsor":"Ensysce Biosciences","startDate":"2022-06-10","conditions":"Recreational Drug Use","enrollment":27},{"nctId":"NCT05571345","phase":"PHASE1","title":"A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)","status":"COMPLETED","sponsor":"Ensysce Biosciences","startDate":"2022-10-05","conditions":"Recreational Drug Use","enrollment":32},{"nctId":"NCT04310579","phase":"PHASE1","title":"Clinical Study to Investigate the Effect of the Combination of Psychotropic Drugs and an Opioid on Ventilation","status":"COMPLETED","sponsor":"Food and Drug Administration (FDA)","startDate":"2020-06-15","conditions":"Hypercapnia, Ventilatory Depression","enrollment":55},{"nctId":"NCT05375916","phase":"NA","title":"Comparison of Short-term Sustained-release Opioid in Open Abdominal Urologic Surgeries","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2022-05-03","conditions":"Pain, Acute, Opioid Use","enrollment":80},{"nctId":"NCT03612713","phase":"EARLY_PHASE1","title":"Influence of Medication on Functional Connectivity","status":"COMPLETED","sponsor":"Yale University","startDate":"2018-10-30","conditions":"Prescription Drug Abuse (Not Dependent)","enrollment":20},{"nctId":"NCT04030442","phase":"PHASE1","title":"Cannabidiol, Morphine, Pain","status":"UNKNOWN","sponsor":"Wayne State University","startDate":"2019-05-01","conditions":"CBD, Chronic Pain","enrollment":40},{"nctId":"NCT04087317","phase":"NA","title":"Vaginal Postpartum Pain Management Protocol Comparison","status":"COMPLETED","sponsor":"Rambam Health Care Campus","startDate":"2020-06-01","conditions":"Pain, Post Partum Depression, Opioid Use","enrollment":200},{"nctId":"NCT00226395","phase":"PHASE3","title":"Efficacy and Safety of Oxymorphone Immediate Release in Post-surgical Acute Pain","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2004-09","conditions":"Acute Pain","enrollment":320},{"nctId":"NCT04223609","phase":"PHASE1, PHASE2","title":"Non-intrusive Detection of Temporary Neurologic Impairment By Opioids","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2020-02-28","conditions":"Healthy","enrollment":14},{"nctId":"NCT02939209","phase":"PHASE4","title":"Pre-emptive Opioid Treatment to Prevent Rebound Pain After Arthroscopic Rotator Cuff Repair and/or Acromioplasty Under General Anesthesia and Interscalene Block","status":"COMPLETED","sponsor":"Vishal Uppal","startDate":"2017-04-20","conditions":"Rotator Cuff Injury, Pain","enrollment":73},{"nctId":"NCT04530162","phase":"","title":"Prevention of Post Herpetic Neuralgia by Ultrasound Guided Single Nerve Block in the ED","status":"WITHDRAWN","sponsor":"Antonios Likourezos","startDate":"2021-10-01","conditions":"Pain","enrollment":""},{"nctId":"NCT04808531","phase":"PHASE3","title":"NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers","status":"UNKNOWN","sponsor":"Medlab Clinical","startDate":"2023-11","conditions":"Cancer Related Pain","enrollment":360},{"nctId":"NCT02487108","phase":"PHASE3","title":"Study to Evaluate the Analgesic Efficacy and Safety of Hydrocodone Bitartrate/Acetaminophen Immediate-Release Tablets in Participants With Moderate to Severe Pain Following Bunionectomy","status":"COMPLETED","sponsor":"Teva Branded Pharmaceutical Products R&D, Inc.","startDate":"2015-08-11","conditions":"Pain","enrollment":569},{"nctId":"NCT03088826","phase":"PHASE2","title":"Analgesic Efficacy of (MSIR)/Acetaminophen vs. Oxycodone/Acetaminophen (Percocet)","status":"COMPLETED","sponsor":"Antonios Likourezos","startDate":"2017-08-18","conditions":"Pain Management","enrollment":80},{"nctId":"NCT02687451","phase":"PHASE3","title":"Clinical Study to Evaluate the Effectiveness, Safety, and Tolerability of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects","status":"TERMINATED","sponsor":"Endo Pharmaceuticals","startDate":"2016-04","conditions":"Post-Operative Pain, Acute Pain","enrollment":28},{"nctId":"NCT02351700","phase":"PHASE4","title":"Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors","status":"COMPLETED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2015-02-01","conditions":"Pituitary Tumor, Pain","enrollment":62},{"nctId":"NCT02740114","phase":"PHASE3","title":"Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-08-31","conditions":"Malignant Neoplasms of Female Genital Organs, Gynecologic Cancer","enrollment":105},{"nctId":"NCT01210352","phase":"PHASE3","title":"Effectiveness, Safety, and Tolerability Study of Oxymorphone Immediate Release (IR) Oral Liquid in Post Surgical Pediatric Subjects","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2010-12-13","conditions":"Post Operative Pain","enrollment":61},{"nctId":"NCT03564548","phase":"PHASE2","title":"Inhaled Cannabinoids Versus Immediate-release Oral Opioids for the Management of Breakthrough Cancer Pain","status":"UNKNOWN","sponsor":"Tetra Bio-Pharma","startDate":"2021-05-26","conditions":"Cancer, Breakthrough Cancer Pain","enrollment":20},{"nctId":"NCT03757559","phase":"PHASE1","title":"A Trial to Evaluate the Abuse Potential of 3 Doses of GRT6005 in Adult Non-dependent Recreational Opioid Users","status":"COMPLETED","sponsor":"Tris Pharma, Inc.","startDate":"2013-04-15","conditions":"Abuse, Drug","enrollment":226},{"nctId":"NCT04234516","phase":"PHASE4","title":"Anti-suicidal Effects of Buprenorphine in Opioid Use Disorder","status":"WITHDRAWN","sponsor":"New York State Psychiatric Institute","startDate":"2020-01-20","conditions":"Opioid-use Disorder, Suicidal Ideation","enrollment":""},{"nctId":"NCT04033094","phase":"","title":"Baseline Epidemiologic Assessment of Abuse-Deterrence of MorphaBond Extended Release (BEAD-MB)","status":"COMPLETED","sponsor":"Daiichi Sankyo","startDate":"2017-10-16","conditions":"Baseline Epidemiologic Assessment","enrollment":17566},{"nctId":"NCT04243954","phase":"PHASE2","title":"Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration","status":"COMPLETED","sponsor":"Fujian Cancer Hospital","startDate":"2020-04-10","conditions":"Cancer Pain","enrollment":95},{"nctId":"NCT00765856","phase":"PHASE3","title":"Open-Label Safety and Tolerability of Oxymorphone IR and ER in Opioid Tolerant Pediatric Subjects","status":"TERMINATED","sponsor":"Endo Pharmaceuticals","startDate":"2008-11-17","conditions":"Chronic Pain","enrollment":27},{"nctId":"NCT04635852","phase":"PHASE2","title":"Fentanyl Buccal Tablet for the Relief of Episodic Breathlessness in Cancer Patients","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2013-03","conditions":"Cancer, Dyspnea, Paroxysmal","enrollment":10},{"nctId":"NCT04533243","phase":"PHASE3","title":"Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain","status":"UNKNOWN","sponsor":"Fujian Cancer Hospital","startDate":"2020-09-01","conditions":"Opioid, Moderate Cancer Pain, Transdermal Fentanyl, 12.5ug/h, Opioid-naive","enrollment":209},{"nctId":"NCT04308525","phase":"","title":"Optimising Microsurgical Reconstruction After Advanced Head and Neck Cancers","status":"UNKNOWN","sponsor":"Rigshospitalet, Denmark","startDate":"2019-06-01","conditions":"Head and Neck Cancer","enrollment":25},{"nctId":"NCT03176121","phase":"PHASE4","title":"Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain","status":"COMPLETED","sponsor":"Taiwan Mundipharma Pharmaceuticals Ltd.","startDate":"2016-10-31","conditions":"Cancer, Pain","enrollment":73},{"nctId":"NCT03176199","phase":"PHASE4","title":"A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain","status":"COMPLETED","sponsor":"Taiwan Mundipharma Pharmaceuticals Ltd.","startDate":"2016-09-01","conditions":"Cancer, Pain","enrollment":30},{"nctId":"NCT03275012","phase":"PHASE2","title":"Efficacy and Safety Study of Gabapentin as add-on to Morphine in Paediatric Patients Affected by Chronic Pain","status":"WITHDRAWN","sponsor":"Pharmaceutical Research Management srl","startDate":"2017-04-04","conditions":"Chronic Pain","enrollment":""},{"nctId":"NCT00478023","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain After Abdominal Hysterectomy","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2007-05","conditions":"Hysterectomy, Postoperative","enrollment":854},{"nctId":"NCT01643772","phase":"PHASE1","title":"OxyNorm® Capsules (Immediate-Release) Pharmacokinetic (PK) Study","status":"COMPLETED","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","startDate":"2011-05","conditions":"Pain","enrollment":61},{"nctId":"NCT03824834","phase":"PHASE2","title":"Morphine to Maximize the Benefits of Exercise Training in COPD or ILD and Persistent Breathlessness","status":"UNKNOWN","sponsor":"Dennis Jensen, Ph.D.","startDate":"2019-08-06","conditions":"Chronic Obstructive Pulmonary Disease, Interstitial Lung Disease","enrollment":40},{"nctId":"NCT03529331","phase":"PHASE4","title":"A Study Comparing Recurrent Use of MSIR, Percocet, and Vicodin at Discharge From the ED","status":"WITHDRAWN","sponsor":"Antonios Likourezos","startDate":"2019-09-01","conditions":"Pain","enrollment":""},{"nctId":"NCT02198924","phase":"PHASE4","title":"Efficacy and Safety of Postoperative Intravenous Parecoxib Sodium Followed by Oral Celecoxib in Osteoarthritis Patients","status":"COMPLETED","sponsor":"Peking Union Medical College Hospital","startDate":"2014-12","conditions":"Pain, Inflammation","enrollment":246},{"nctId":"NCT03314792","phase":"PHASE4","title":"Effects of Tapentadol Versus Oxycodone After Hysterectomy.","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"2017-12-04","conditions":"Pain, Postoperative, Pain Uterus, Pain, Acute","enrollment":86},{"nctId":"NCT00986258","phase":"PHASE3","title":"Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking WHO Step III Analgesics But Showing a Lack of Tolerability","status":"TERMINATED","sponsor":"Grünenthal GmbH","startDate":"2009-10-30","conditions":"Pain, Chronic Pain, Low Back Pain","enrollment":136},{"nctId":"NCT00743587","phase":"PHASE1","title":"A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Osteoarthritis Thumbs","enrollment":36},{"nctId":"NCT01677065","phase":"","title":"A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-09","conditions":"Healthy","enrollment":14},{"nctId":"NCT01675622","phase":"PHASE3","title":"Immediate-Release Oxycodone Capsules Study in Cancer Pain","status":"COMPLETED","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","startDate":"2011-01","conditions":"Cancer","enrollment":242},{"nctId":"NCT03475862","phase":"PHASE1","title":"Nasal Human Abuse Potential of PTI-821","status":"COMPLETED","sponsor":"Pain Therapeutics","startDate":"2017-05-15","conditions":"Opioid Abuse Nondependent","enrollment":38},{"nctId":"NCT01675635","phase":"PHASE3","title":"OxyNorm Capsules in Post-Operative Pain Study","status":"COMPLETED","sponsor":"Mundipharma (China) Pharmaceutical Co. Ltd","startDate":"2011-07","conditions":"Postoperative Pain","enrollment":240},{"nctId":"NCT00994383","phase":"NA","title":"Comparative Bioavailability Study of Morphine Sulfate Immediate Release and Controlled Release","status":"COMPLETED","sponsor":"Roxane Laboratories","startDate":"2007-01","conditions":"Pain","enrollment":36},{"nctId":"NCT03137030","phase":"PHASE1","title":"A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of Different Amounts of Tablets of a New and a Marketed Tablet Formulation in Healthy Adults","status":"WITHDRAWN","sponsor":"Grünenthal GmbH","startDate":"2017-09","conditions":"Opioid-Related Disorders, Pain, Acute, Pain, Postoperative","enrollment":""},{"nctId":"NCT03137017","phase":"PHASE1","title":"A Comparison of Plasma Concentrations of Hydrocodone and Acetaminophen After Administration of a New and a Marketed Tablet Formulation Under Fasted and Fed Conditions in Healthy Adults","status":"WITHDRAWN","sponsor":"Grünenthal GmbH","startDate":"2017-09","conditions":"Opioid-Related Disorders, Pain, Acute, Pain, Postoperative","enrollment":""},{"nctId":"NCT01502644","phase":"PHASE4","title":"Opioid Treatment for Chronic Low Back Pain and the Impact of Mood Symptoms","status":"COMPLETED","sponsor":"Brigham and Women's Hospital","startDate":"2009-02","conditions":"Chronic Low Back Pain, Degenerative Disc Disease, Depression","enrollment":81},{"nctId":"NCT00158184","phase":"PHASE2","title":"Prescription Opioid Effects in Abusers Versus Non-Abusers","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2004-06","conditions":"Opioid-Related Disorders, Substance-Related Disorders","enrollment":27},{"nctId":"NCT02572375","phase":"PHASE1","title":"Codeine Phosphate/Guaifenesin ER Tablet 30 mg/600 mg Steady State Clinical Study","status":"COMPLETED","sponsor":"Nexgen Pharma, Inc","startDate":"2014-10","conditions":"Cough","enrollment":38},{"nctId":"NCT01871285","phase":"PHASE2","title":"Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film","status":"COMPLETED","sponsor":"BioDelivery Sciences International","startDate":"2013-06","conditions":"Pain","enrollment":39},{"nctId":"NCT00853320","phase":"PHASE1","title":"Fasting Study of Oxycodone Hydrochloride 15 mg Tablets and Roxicodone™ 15 mg Tablets","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2003-02","conditions":"Healthy","enrollment":38},{"nctId":"NCT00853216","phase":"PHASE1","title":"Fasting Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2003-01","conditions":"Healthy","enrollment":38},{"nctId":"NCT00853736","phase":"PHASE1","title":"Fed Study of Oxycodone Hydrochloride 30 mg Tablets and Roxicodone™ 30 mg Tablets","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2003-02","conditions":"Healthy","enrollment":23},{"nctId":"NCT00802087","phase":"PHASE1","title":"Single Dose Pharmacokinetics of Egalet® Hydrocodone","status":"COMPLETED","sponsor":"Egalet Ltd","startDate":"2008-11","conditions":"Pain","enrollment":28},{"nctId":"NCT02773316","phase":"PHASE1","title":"Study to Assess Pharmacokinetic (PK), Bioavailability & Food Effect of MR902 Compared With Immediate Release (IR) Morphine Sulphate Oral Solution","status":"COMPLETED","sponsor":"Mundipharma Research Limited","startDate":"2015-09","conditions":"Opioid Substitution Treatment","enrollment":84},{"nctId":"NCT01946555","phase":"","title":"Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain","status":"COMPLETED","sponsor":"Mario Negri Institute for Pharmacological Research","startDate":"2013-09","conditions":"Tumor, Cancer Pain, Breakthrough Cancer Pain","enrollment":150},{"nctId":"NCT00558870","phase":"PHASE2","title":"Role of Methadone As Co-Opioid Analgesic","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2007-11","conditions":"Pain","enrollment":5},{"nctId":"NCT01986283","phase":"PHASE1","title":"Abuse Potential Study of PF-00345439","status":"COMPLETED","sponsor":"Pain Therapeutics","startDate":"2013-11","conditions":"Opioid Users","enrollment":67},{"nctId":"NCT00573937","phase":"PHASE2","title":"Methadone Versus Morphine for Cancer-Related Pain","status":"TERMINATED","sponsor":"Mayo Clinic","startDate":"2007-08","conditions":"Neoplasms, Pain","enrollment":1},{"nctId":"NCT00580294","phase":"NA","title":"A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2007-11","conditions":"Pain","enrollment":12},{"nctId":"NCT01672112","phase":"PHASE4","title":"Comparison of the Efficacy of Oral Oxycodone and Oral Codeine in the Treatment of Postcraniotomy Pain","status":"COMPLETED","sponsor":"Tan Tock Seng Hospital","startDate":"2012-07","conditions":"Postcraniotomy Pain","enrollment":40},{"nctId":"NCT02157649","phase":"PHASE1","title":"Single Dose Trial of Extended Release Combination Tablet Codeine and Guaifenesin","status":"COMPLETED","sponsor":"Nexgen Pharma, Inc","startDate":"2014-06","conditions":"Cough","enrollment":26},{"nctId":"NCT00201539","phase":"PHASE3","title":"Double Bedtime Dosing During Immediate-release Morphine Administration to Cancer Patients","status":"COMPLETED","sponsor":"Norwegian University of Science and Technology","startDate":"2002-04","conditions":"Cancer","enrollment":19},{"nctId":"NCT00613938","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2008-02","conditions":"Arthralgia, Bunion, Hallux Valgus","enrollment":901},{"nctId":"NCT00935311","phase":"PHASE2","title":"Hydrocodone/Acetaminophen for Acute Pain Following Third Molar Tooth Extraction","status":"COMPLETED","sponsor":"AbbVie (prior sponsor, Abbott)","startDate":"2009-06","conditions":"Pain","enrollment":122},{"nctId":"NCT01507220","phase":"PHASE4","title":"A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301","status":"TERMINATED","sponsor":"Pacira Pharmaceuticals, Inc","startDate":"2012-03","conditions":"Bowel Obstruction","enrollment":2},{"nctId":"NCT01837394","phase":"PHASE4","title":"Ultrasound-guided Blocks for Ambulatory Knee Arthroscopy","status":"COMPLETED","sponsor":"Jens Borglum Neimann","startDate":"2012-08","conditions":"Postoperative Pain, Postoperative Nausea and Vomiting, Postoperative Function Level","enrollment":60},{"nctId":"NCT00751478","phase":"PHASE1, PHASE2","title":"Study to Determine the Bioavailability, Pharmacodynamic Effects, and Safety of Whole and Crushed ALO-01 Compared to Morphine Sulfate Immediate Release (MSIR)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-03","conditions":"Healthy","enrollment":32},{"nctId":"NCT01500317","phase":"PHASE4","title":"Comparison of the Effects of Tapentadol and Oxycodone on Gastrointestinal and Colonic Transit in Humans","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2011-05","conditions":"Effects of 2 Mu-opiates on Gastrointestinal Transit","enrollment":38},{"nctId":"NCT00404222","phase":"PHASE2","title":"A Study Comparing Vicodin® CR and NORCO® to Placebo in Subjects With Acute Pain Following Bunionectomy","status":"COMPLETED","sponsor":"Abbott","startDate":"2005-11","conditions":"Pain","enrollment":90},{"nctId":"NCT00410540","phase":"PHASE3","title":"A Study of OROS Hydromorphone HCL vs Morphine in Cancer Pain Patients.","status":"COMPLETED","sponsor":"Alza Corporation, DE, USA","startDate":"","conditions":"Pain, Analgesics, Opioid","enrollment":202},{"nctId":"NCT00978328","phase":"","title":"Oxycodone User Registry (OUR)","status":"COMPLETED","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","startDate":"2009-06","conditions":"Pain","enrollment":827},{"nctId":"NCT00589823","phase":"PHASE3","title":"Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids","status":"COMPLETED","sponsor":"Archimedes Development Ltd","startDate":"2007-06","conditions":"Cancers, Pain","enrollment":135},{"nctId":"NCT00125801","phase":"PHASE3","title":"The Pain Pen for Breakthrough Cancer Pain","status":"TERMINATED","sponsor":"Erasmus Medical Center","startDate":"2005-08","conditions":"Neoplasms, Pain","enrollment":50},{"nctId":"NCT00635063","phase":"PHASE3","title":"A Multicentre Study to Evaluate the Safety and Efficacy of AD 923 in Comparison to MSIR for the Treatment of CBP in Subjects","status":"TERMINATED","sponsor":"Sosei","startDate":"2008-02","conditions":"Cancer, Pain","enrollment":150},{"nctId":"NCT00390312","phase":"PHASE2","title":"Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction","status":"COMPLETED","sponsor":"Javelin Pharmaceuticals","startDate":"2001-09","conditions":"Post-Operative Pain, Third Molar Extraction","enrollment":225}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["IRMS","Morphine Solution"],"phase":"phase_3","status":"active","brandName":"Immediate release morphine sulphate","genericName":"Immediate release morphine sulphate","companyName":"Archimedes Development Ltd","companyId":"archimedes-development-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Immediate release morphine sulphate is used to treat pain, particularly cancer pain, and opioid-induced constipation.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}